Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

The Emmental Enigma

Those of you that have followed this blog know that I have commented a few times on the impact on fragmentation when a primary market has been unavailable (see the croissant hypothesis and the bacon roll theory). Well, yesterday it was the turn of SIX Group to run the experiment. Due to a technical glitch, SIX was unable to provide prices on major Swiss stocks for a few hours yesterday afternoon. A quick spin through the Fragulator shows some intriguing results that seem to counter the conclusions that were drawn before.

Total average volume of SMI stocks was around 111,000 trades on the 3 days prior to the problem. This fell by around 30% yesterday due to the outage, but the interesting bit is how the remaining volume traded. Chi-X, BATS, Turquoise and Nasdaq Europe all traded the same or greater volumes than they had previously despite the fact that the primary market was unavailable. This seems to counter the view that traders ignore a stock altogether when primary markets are down and, as a result, price formation happily took place between the MTFs only without the need for a “parent” exchange. What this shows is that, for Swiss stocks at least, the MTFs are now regarded as completely legitimate venues in terms of providing credible price formation even when the primary is down.

It’s not all going the MTFs way though, as further analysis shows that OTC trading increased by 46% yesterday when compared with the average of the three days before. OTC trading, therefore, was actually an even bigger winner than the MTF community as a result of the SIX outage.

The MTFs that find ways to attract this volume onto their own dark segments could be the liquidity winners of the future.

Leave a comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.